Form 4: Myomo Inc. Chief Medical Officer Harry Kovelman Reports Stock Sale for Tax Obligations

Harry Kovelman, Chief Medical Officer of Myomo, Inc., reports the sale of 146 shares of common stock to cover income taxes resulting from the vesting of restricted stock units.

Summary

• On May 3, 2024, Harry Kovelman, the Chief Medical Officer of Myomo, Inc., sold 146 shares of common stock.
• The sale was executed at a price of $3.84 per share.
• This transaction was conducted to cover income taxes resulting from the vesting of restricted stock units on May 2, 2024.
• The sale was completed pursuant to an irrevocable election made by Kovelman in conjunction with the original grant in November 2020.
• Following the transaction, Kovelman directly owns 133,435 shares of Myomo, Inc. common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the filing simply reports a routine stock sale to cover tax obligations, which is a common practice.

Industry Context

Form 4 filings are standard practice for company insiders to report changes in their beneficial ownership of company stock, providing transparency to investors.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it involves a small number of shares sold by an executive to cover tax obligations.

Key Dates